1. Department of Bioengineering and Institute of Nanoscience and Technology, Hanyang University, Seoul, Korea;
2. Department of Internal Medicine, Section of Infectious Diseases, Yale University School of Medicine, New Haven, CT, USA;
3. Samsung Bioepis, Incheon, Korea;
4. Celltrion, Incheon, Korea;
5. Chong Kun Dang Pharmaceutics, Seoul, Korea;
6. Department of Health Services, Policy, and Practice, Brown University, Providence, RI, USA;
7. Center for Theragnosis, Biomedical Research Institute, Korea Institute of Science and Technology, Seoul, Korea